The market for diagnostic imaging in Saudi Arabia is majorly influenced by factors such as increasing chronic diseases burden in the country along with the rising geriatric population. These factors are fuelling market growth in Saudi Arabia.

A survey from the National Institute of Health (NIH) has stated that the demographic composition of Saudi Arabia has changed due to the increased life expectancy and decreased fertility rate. This factor is augmenting the growth of elderly people in the country. Estimations from organizations such as NIH has suggested that 20% of people in the country will be aged above 65 years by 2050.

Added to that, Saudi Arabia is the leading country in the globe with a high prevalence of chronic diseases and their associated risk factors. For instance, one in every four adults in the country is either obese or diabetic. The prevalence of Hypertension is 25% and that of coronary heart disease is around 6%, as per the statistic of NIH.

The burden of chronic diseases in Saudi Arabia is augmenting the demand for diagnosis which is propelling the growth of the diagnostic imaging market in the country.

Key Market Trends

Oncology is Expected to Witness Rapid Growth Over the Forecast Period

Due to the growing incidence of cancer and the rising mortality rate in Saudi Arabia, the oncology segment is expected to witness rapid growth over the forecast period.

As per the latest statistics by the World Health Organization, 24,485 new cancer cases were diagnosed during the year 2018. Among these, 12,263 were men and 12,222 were females. Among the females, breast cancer was the most common cancer and contributed to 29.7% of the total cancers in females. Colorectal cancer was the most common cancer for males in Saudi Arabia which contributed to 19.6% of all cancers in males. Furthermore, during the same year, 10,518 deaths due to cancer were recorded in Saudi Arabia. Therefore, the demand for diagnostic imaging to reduce cancer cases and provide better treatment is increasing.

Diagnostic imaging plays a vital role in interventional oncology (with rising opportunities to diagnose and treat in a targeted and minimally or non-invasive manner) as well as in chemo and radiation therapy. Equipment, such as CT, is the highly beneficial and preferred method of imaging for many conditions, including trauma patients. Comparatively, PET is mostly preferred as compared to SPECT, and there are hybrid medical devices also available such as PET/CT or PET/MRI.

Competitive Landscape

The market for diagnostic imaging in Saudi Arabia is moderately competitive and consists of the global players along with a few local players. Due to the rising focus of companies to expand to the Middle East region, the Saudi Arabian market is witnessing a large number of these players with an active presence. With technological advancements and product innovation, more companies are expected to penetrate the market in the coming future.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support